Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 10,551 |
|
|||||
| News | - | ||||||
| Day High | 5.4068 | Low High |
|||||
| Day Low | 5.20 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Palisade Bio Inc | PALI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.11 | -2.03% | 5.30 | 14:00:22 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.38 | 5.20 | 5.4068 | 5.41 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 139 | 10,551 | $ 5.32 | $ 56,111 | - | 3.82 - 36.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:08:03 | 1 | $ 5.265 | USD |
Palisade Bio Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 20.14M | 12.13M | - | 250k | -12.3M | -1.01 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Palisade Bio News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PALI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.23 | 6.6499 | 5.20 | 6.05 | 39,710 | -0.93 | -14.93% |
| 1 Month | 5.69 | 9.09 | 5.20 | 7.03 | 724,020 | -0.39 | -6.85% |
| 3 Months | 6.135 | 9.09 | 3.82 | 6.15 | 1,153,662 | -0.835 | -13.61% |
| 6 Months | 8.70 | 22.35 | 3.82 | 11.23 | 1,898,739 | -3.40 | -39.08% |
| 1 Year | 22.50 | 36.60 | 3.82 | 15.52 | 1,771,272 | -17.20 | -76.44% |
| 3 Years | 2,782.50 | 3,427.50 | 3.82 | 231.21 | 1,976,258 | -2,777.20 | -99.81% |
| 5 Years | 6,750.00 | 8,182.50 | 3.82 | 346.08 | 1,997,356 | -6,744.70 | -99.92% |
Palisade Bio Description
| Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery. |
